Last reviewed · How we verify
IMIDOCARB
At a glance
| Generic name | IMIDOCARB |
|---|---|
| Target | Acetylcholinesterase |
| Modality | Small molecule |
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
Approved indications
Common side effects
- Pain during injection
- Salivation
- Nasal drip
- Vomiting
- Panting
- Restlessness
- Diarrhea
- Mild injection site inflammation
Serious adverse events
- Severe cholinergic signs
- Injection site ulceration
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IMIDOCARB CI brief — competitive landscape report
- IMIDOCARB updates RSS · CI watch RSS